Large-scale testing (Phase 3)Study completedNCT02545543
What this trial is testing
Evaluate the Immunogenicity and Safety of Seqirus Quadrivalent Influenza Vaccine (QIV) in a Pediatric Population 5 Through 17 Years of Age
Who this might be right for
Influenza, Human
Seqirus 2,278